Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD

Clinical trial NCT05326412 · COMPLETED

Trial details

NCT number: NCT05326412
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2022-05-19
Primary completion: 2025-03-05
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.